Sumitomo Mitsui Trust Holdings Inc. Sells 39,283 Shares of Xylem Inc. (NYSE:XYL)

Sumitomo Mitsui Trust Holdings Inc. cut its holdings in Xylem Inc. (NYSE:XYLFree Report) by 6.7% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 551,318 shares of the industrial products company’s stock after selling 39,283 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.23% of Xylem worth $74,775,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. EverSource Wealth Advisors LLC grew its holdings in shares of Xylem by 68.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after purchasing an additional 77 shares during the last quarter. Blue Trust Inc. increased its holdings in shares of Xylem by 1,185.7% during the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after buying an additional 249 shares in the last quarter. FinTrust Capital Advisors LLC lifted its stake in shares of Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after acquiring an additional 200 shares during the last quarter. Hazlett Burt & Watson Inc. boosted its holdings in shares of Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after acquiring an additional 220 shares in the last quarter. Finally, Spire Wealth Management grew its position in Xylem by 370.9% during the 4th quarter. Spire Wealth Management now owns 485 shares of the industrial products company’s stock worth $54,000 after acquiring an additional 382 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 0.3 %

NYSE XYL traded down $0.39 during trading hours on Friday, hitting $132.80. 1,956,508 shares of the company’s stock were exchanged, compared to its average volume of 1,220,650. The firm has a market cap of $32.26 billion, a price-to-earnings ratio of 47.26, a PEG ratio of 2.32 and a beta of 1.04. The stock has a 50-day simple moving average of $135.52 and a 200 day simple moving average of $132.26. The company has a current ratio of 1.85, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 1-year low of $87.59 and a 1-year high of $146.08.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $1.09 EPS for the quarter, topping the consensus estimate of $1.05 by $0.04. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The company had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.14 billion. During the same quarter last year, the firm posted $0.98 EPS. The company’s quarterly revenue was up 26.0% on a year-over-year basis. On average, equities analysts forecast that Xylem Inc. will post 4.25 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th will be issued a $0.36 dividend. The ex-dividend date is Thursday, August 29th. This represents a $1.44 annualized dividend and a yield of 1.08%. Xylem’s payout ratio is currently 51.25%.

Insider Buying and Selling at Xylem

In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the stock in a transaction on Monday, June 10th. The stock was sold at an average price of $138.63, for a total value of $315,799.14. Following the transaction, the chief accounting officer now directly owns 3,536 shares in the company, valued at approximately $490,195.68. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other Xylem news, SVP Rodney Aulick sold 21,800 shares of the business’s stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the sale, the senior vice president now directly owns 76,287 shares of the company’s stock, valued at approximately $10,604,655.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Geri-Michelle Mcshane sold 2,278 shares of the stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $138.63, for a total value of $315,799.14. Following the completion of the sale, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at $490,195.68. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

Wall Street Analysts Forecast Growth

XYL has been the subject of several research reports. Mizuho increased their target price on Xylem from $110.00 to $135.00 and gave the company a “neutral” rating in a research report on Friday, May 3rd. Stifel Nicolaus boosted their target price on shares of Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a report on Wednesday, July 31st. TD Cowen raised their price target on shares of Xylem from $135.00 to $138.00 and gave the company a “buy” rating in a research note on Thursday, June 6th. UBS Group assumed coverage on shares of Xylem in a research note on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price objective on the stock. Finally, Argus raised their target price on Xylem from $146.00 to $165.00 and gave the stock a “buy” rating in a research report on Wednesday, May 29th. Five equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $147.54.

View Our Latest Analysis on Xylem

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.